Newest first
New topics page 37
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 37 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: indirect comparison between two programmes, defended and attacked — one year on
Posting this under the heading it deserves: Journal club: indirect comparison between two programmes, defended and attacked — one year on Everything below is what sits behind that. Asking about indirect…
|
+45 | 50 | 3k | 9mo |
|
About the Semaglutide category
GLP-1 receptor agonist. Dosing, published trial data, tolerability, and formulation questions. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 4.2k | 11mo | |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for personal quantities in a thread last spring…
|
3 | 60k | 12mo | |
|
Coming back to: Oxidation and deamidation mass shifts, tabulated
Oxidation and deamidation mass shifts, tabulated — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about Oxidation and deamidation mass…
|
+34 | 38 | 4.8k | 10mo |
|
How to bring a laboratory report to an appointment usefully
How to bring a laboratory report to an appointment usefully — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about bring a laboratory directly, because I have…
|
2 | 41k | 14mo | |
|
A well-designed study with a badly written abstract
Posting this under the heading it deserves: A well-designed study with a badly written abstract Everything below is what sits behind that. Reading back through what has been written here about well-designed…
|
+117 | 128 | 7.2k | 14mo |
|
Coming back to: Over-dilution: when your dose falls below one readable graduation
Over-dilution: when your dose falls below one readable graduation Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
|
+90 | 97 | 1.1k | 7mo |
|
A certificate with no method stated: what can you conclude?
A certificate with no method stated: what can you conclude? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what this number means before I…
|
+49 | 57 | 1.2k | 16mo |
|
Retatrutide phase 2 in type 2 diabetes: the Lancet paper
On the subject in the title: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Working notes rather than a conclusion. Asking about retatrutide phase 2 in type on behalf of the question I keep seeing…
|
+12 | 16 | 50k | 12mo |
|
Review cadence: how often is a page actually re-checked?
Asking directly, because I could not find a straight answer: Review cadence: how often is a page actually re-checked? I would like to know what people here actually do about review cadence, as distinct from…
|
+20 | 24 | 20k | 15mo |
|
[2026 update] Building a sensible monitoring schedule with your prescriber
Posting this under the heading it deserves: Building a sensible monitoring schedule with your prescriber Everything below is what sits behind that. Reading back through what has been written here about…
|
+22 | 26 | 5.1k | 14mo |
|
Excipient function in a licensed injectable
Excipient function in a licensed injectable Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about excipient function in a thread last spring and I would like to…
|
+3 | 7 | 36k | 14mo |
|
Sequence verification for an obscure compound: how it is done
Sequence verification for an obscure compound: how it is done Writing it up because I had to work it out twice and would rather nobody else did. Asking about sequence verification directly, because I have…
|
+104 | 114 | 10k | 12mo |
|
Second pass at: Reading a combination trial: attributing effect to components
Second pass at: Reading a combination trial: attributing effect to components — setting out what I have, and where I think it stops being reliable. The question about Reading a combination trial that I…
|
+39 | 43 | 7.3k | 12mo |
|
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Posting this under the heading it deserves: Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Everything below is what sits behind that. Reading back through what has been written here about…
|
+4 | 8 | 14k | 8mo |
|
Needle changes between doses on a reusable pen
Posting this under the heading it deserves: Needle changes between doses on a reusable pen Everything below is what sits behind that. The question about needle changes between doses that I actually want…
|
+34 | 38 | 1.5k | 10mo |
|
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. Cross-border purchase rules within — I have the observation and I do not trust my…
|
+12 | 16 | 2.8k | 11mo |
|
Coming back to: A critique that turned out to be unfair, retracted by its author
A critique that turned out to be unfair, retracted by its author — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about critique, three…
|
2 | 1.3k | 14mo | |
|
Comparators chosen for regulatory reasons rather than clinical ones — one year on
Comparators chosen for regulatory reasons rather than clinical ones — one year on — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Comparators chosen for…
|
+82 | 87 | 1.1k | 12mo |
|
Aggregated purity results across four services, with caveats
Posting this under the heading it deserves: Aggregated purity results across four services, with caveats Everything below is what sits behind that. Aggregated purity results across four, from the point of…
|
3 | 24k | 9mo | |
|
An appeal that failed, and what I would do differently
An appeal that failed, and what I would do differently Writing it up because I had to work it out twice and would rather nobody else did. Asking about appeal directly, because I have read four threads on it…
|
+4 | 8 | 125 | 12mo |
|
Why cagrilintide alone is discussed so much less than in combination
Why cagrilintide alone is discussed so much less than in combination I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about cagrilintide alone…
|
+93 | 108 | 35k | 16mo |
|
Publishing an inconvenient result: a case study
On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Publishing an inconvenient result, and specifically the version of it that the…
|
+59 | 70 | 992 | 11mo |
|
Coming back to: Why quantitation is the hard part, not detection
Why quantitation is the hard part, not detection — that is the question, and I have not found it answered plainly anywhere I have looked. Collecting what is known about quantitation in one place, because it…
|
+86 | 92 | 54k | 8mo |
|
Follow-up: The lowest dose that does anything: is that a real question?
The question in the title: The lowest dose that does anything: is that a real question? I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still…
|
+70 | 75 | 12k | 8mo |
|
A supplier who responds to a discrepancy with silence
On the subject in the title: A supplier who responds to a discrepancy with silence Working notes rather than a conclusion. Two things I would like separated before anyone answers on supplier, because they get…
|
2 | 6.1k | 16mo | |
|
What happens after your first post: likes, trust levels, and why none of it matters much
Asking directly, because I could not find a straight answer: What happens after your first post: likes, trust levels, and why none of it matters much I want to check my reasoning rather than get a conclusion.…
|
+15 | 19 | 17k | 16mo |
|
Documenting a supplier's response to a discrepancy — does this still hold?
Documenting a supplier's response to a discrepancy — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Structured question about turnaround and…
|
+47 | 52 | 58k | 16mo |
|
Units, standards, and other things that quietly hold the world together
Units, standards, and other things that quietly hold the world together — setting out what I have, and where I think it stops being reliable. I was wrong about units in a thread last spring and I would like…
|
+33 | 38 | 31k | 15mo |
|
Asking about a compound your prescriber has not heard of
Asking about a compound your prescriber has not heard of Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician rather…
|
+137 | 148 | 15k | 11mo |